Fundraising Fox
Affini-T
8 employees on LinkedIn · 9 known investors
Find your way into Affini-T
Sign up to see every warm intro you have to Affini-T
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Affini-T team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities. The company operates in the biotech and cancer immunotherapy space.
Investors · 9
How we know: Agent Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Jacket River Capital Partners's portfolio page · Not right? Tell us
How we know: Olive Tree Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · businessinsider.com · Not right? Tell us
How we know: funding news · fiercebiotech.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$175M disclosed across 1 of 2 rounds · 2022
- Undisclosed amountSeries A and BMar 2022
Leaps by Bayer (lead), Vida Ventures (lead)
Source ↗ - $175MraisedMar 2022 · 3 sources
Leaps (lead), Vida Ventures (lead), Fred Hutchinson Cancer Research Center
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Affini-T do?
- Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities. The company operates in the biotech and cancer immunotherapy space.
- Who are Affini-T's investors?
- Affini-T's investors include Agent Capital, Jacket River Capital Partners, Olive Tree Capital, Service Provider Capital, Fred Hutchinson Cancer Research Center, Humboldt, Leaps by Bayer, Vida Ventures.
- How much funding has Affini-T raised?
- Affini-T has disclosed $175M raised across 1 of its 2 known rounds.